Heart stent SUPRAFLEX CRUZ under Post-Market scrutiny for multivessel disease
NCT ID NCT05617599
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 508 patients with multivessel coronary artery disease who received the SUPRAFLEX CRUZ stent during routine care. Researchers are monitoring for heart-related events like heart attacks, repeat procedures, and heart function over 12 months. The goal is to confirm the stent's safety and performance in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SUPRAFLEX CRUZ stent (a medical device used to open blocked heart arteries)
- What this could lead to
- If successful, this study could confirm that the SUPRAFLEX CRUZ stent is safe and effective for treating patients with blockages in multiple heart arteries.
- What could go wrong
- This is an observational post-market study, not a randomized trial, so results may be less definitive. Risks include stent-related complications like blood clots or re-narrowing of arteries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clinico Universitario de Salamanca
RECRUITINGSalamanca, 37007, Spain
-
Hospital Clínico Universitario Virgen de la Arrixaca
RECRUITINGMurcia, 30120, Spain
-
Hospital Clínico Universitario de Santiago de Compostela
RECRUITINGSantiago de Compostela, 15706, Spain
-
Hospital General Universitario de Castellón
RECRUITINGCastelló, 12004, Spain
-
Hospital General Universitario de Ciudad Real
RECRUITINGCiudad Real, 13005, Spain
-
Hospital General Universitario de Elche
RECRUITINGElche, Alicante, 03203, Spain
-
Hospital Parc Tauli
RECRUITINGSabadell, 08208, Spain
-
Hospital Universitari Arnau de Vilanova
RECRUITINGLleida, 25198, Spain
-
Hospital Universitari Dr. Josep Trueta
RECRUITINGGirona, 17007, Spain
-
Hospital Universitari Vall D'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario A Coruña
RECRUITINGA Coruña, 15006, Spain
-
Hospital Universitario Clínico San Cecilio
RECRUITINGGranada, 18016, Spain
-
Hospital Universitario Lozano Blesa
RECRUITINGZaragoza, 50009, Spain
-
Hospital Universitario San Pedro de Alcántara
RECRUITINGCáceres, 10003, Spain
-
Hospital Universitario Virgen Del Rocio
RECRUITINGSeville, 41013, Spain
-
Hospital Universitario Y Politécnico La Fé
RECRUITINGValencia, 46026, Spain
-
Hospital Universitario de Cruces
RECRUITINGBarakaldo, 48903, Spain
-
Hospital Universitario de Leon
RECRUITINGLeón, 24001, Spain
-
Hospital Universitario de Toledo
RECRUITINGToledo, 45007, Spain
-
Hospital de La Santa Creu I Sant Pau
RECRUITINGBarcelona, 08041, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a higher dose of adenosine sharpen heart scans?
- Can we predict which heart blockages will worsen after stenting?
- Can a drop of blood predict disease years before it strikes?
- Can a new catheter make heart stenting safer and more effective?
- Heart rehab may tweak cell death pathways — a study investigates
- Can a trained eye match ultrasound for heart stent placement?